[13]. Recent studies demonstrate that primary hereditary ; abnormalities in the glucocorticoid receptor gene make 6.6% of the normal population relatively `hypersensitive' to glucocorticoids, while 2.3% are relatively "resistant". These abnormalities might explain the well-known phenomenon that some individuals develop severe adverse effects during therapy with a low dose of glucocorticosteroids, while others do not develop side effects even during long-term therapy with a much higher dose [14]. In childhood ALL in vitro glucocorticoid resistance is observed in 4148% patients on diagnosis. After repeated cycles of chemotherapy including glucocorticoids, the rate of glucocorticoid resistance reaches 6090% patients at relapse [1, 15]. The sensitivity to glucocorticoids is thought to be one of the most important prognostic factors in various therapeutic protocols for children with ALL. Prednisolone resistance is thought to be the strongest single adverse prognostic factor [12, 911, 15]. Glucocorticoids are the most important cytotoxic drugs in the therapy of ALL. Recent studies have shown that the response of ALL to glucocorticoid therapy increases with drug dose. High-dose corticosteroid treatment abrogates the effect of relative drug insensitivity and of low glucocorticoid receptor number on peripheral blasts [16]. In our study, based solely on clinical material, we determined in vitro cross-resistance pattern between prednisolone, dexamethasone, betamethasone, methylprednisolone.

Upon the advice of the NCPAG, if an OTC product fails to meet criteria for continued coverage under the pharmacy benefit; DMA may remove the medication from the covered OTC list. This information will be posted to the OTC list according to DMA's clinical coverage policy guidelines, because dexamethasone administration. Hypocholesterolemic Effect of Soy Proteins--Only Due to Protein and Only in Hypercholesterolemics. Cesare R. Sirtori, Dept. of Pharmacological Sciences and University Center for Dyslipidemias, Niguarda Hospital, Milano, Italy. Medications distributed from internet sales may contain dangerous ingredients, or may not be distributed by a licensed pharmacy, for example, thalidomide and dexamethasone.

Chapter 6: It's 100% When Relationships Break Down In adult women, domestic abuse is a hidden cause for many health problems. During a four-week period, about 1 in 7 American women aged 19-49 and 1 in 10 aged 50-69 experience insulting, swearing, threatening, yelling, hitting, or pushing "some, most, or all of the time. Ance."205 Phase III lasts approximately thirty-six weeks, although as in the NOTRE DAME LAW REVIEW [vol. defendant to cycle through Phase III other phases, the court may require a74: 2 again or recycle through Phase II if significant relapses of drug use have occurred. 206 Upon satisfactory completion of the program, the defendant makes a final appearance before the court at which time the Drug Court judge discharges the defendant from the program and the prosecutor then dismisses the charges.207 and divalproex!

The median time to disease progression TTP ; in patients treated with thalidomide plus dexamethasone has not been reached as compared to 8.1 moths months with dexamethasone plus placebo.
REFERENCES 1. Anonymous. 1997. Imiquimod for genital warts. Med. Lett. Drugs Ther. 39: 118119. 2. Arany, I., M. M. Brysk, H. Brysk, and S. K. Tyring. 1996. Response to interferon treatment decreases with epidermal dedifferentiation in condylomas. Antivir. Res. 32: 1926. 3. Arany, I., and S. K. Tyring. 1996. Activation of local cell-mediated immunity in interferon responsive patients with human papillomavirus-associated lesions. J. Interferon Cytokine Res. 16: 453460. 4. Arany, I., and S. K. Tyring. 1996. Status of local cellular immunity in interferon responsive and nonresponsive human papillomavirus-associated lesions. Sex. Transm. Dis. 26: 475480. 5. Beutner, K. R., S. L. Spruance, A. J. Hougham, T. L. Fox, M. L. Owens, and J. M. Douglas, Jr. 1998. Treatment of genital warts with an immune-response modifier imiquimod ; . J. Am. Acad. Dermatol. 38: 230239. 6. Bottrel, R. L. A., Y.-L. Yang, D. E. Levy, M. Tomai, and L. F. L. Reis. 1999. The immune response modifier imiquimod requires STAT-1 for induction of interferon, interferon-stimulated genes, and interleukin-6. Antimicrob. Agents Chemother. 43: 856861. 7. Brysk, M. M., I. Arany, H. Brysk, S.-H. Chen, K. H. Calhoun, and S. K. Tyring. 1995. Epithelial cell responsiveness to interferon gamma: epidermis vs. buccal mucosa. Mol. Cell. Differ. 3: 213223. 8. Brysk, M. M., I. Arany, H. Brysk, S.-H. Chen, K. H. Calhoun, and S. K. Tyring. 1995. Gene expression of markers associated with proliferation and differentiation in keratinocytes cultured from skin and from oral mucosa. Arch. Oral Biol. 40: 855862. 9. Darnell, J. E. 1997. STATs and gene regulation. Science 277: 16301635. 10. Edwards, L., A. Ferenczy, L. Eron, D. Baker, M. L. Owens, T. L. Fox, A. J. Hougham, and K. A. Schmitt. 1998. Self-administered topical 5% imiquimod cream for external anogenital warts. Arch. Dermatol. 134: 2530. 11. Garcia, R., and R. Jove. 1998. Activation of STAT transcription factors in oncogenic tyrosine kinase signaling. J. Biomed. Sci. 5: 7985. 12. Gibson, S. J., L. M. Imbertson, T. L. Wagner, T. L. Testerman, M. J. Reiter, R. L. Miller, and M. A. Tomai. 1995. Cellular requirements for cytokine production in response to the immunomodulators imiquimod and S-27609. J. Interferon Cytokine Res. 15: 537545. 13. Gross, G. 1997. Therapy of human papillomavirus infection and associated epithelial tumors. Intervirology 40: 368377. 14. Harada, H., T. Fujita, M. Miyamoto, Y. Kimura, M. Maruyama, A. Furia, T. Miyata, and T. Taniguchi. 1989. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58: 729739. 15. Harada, H., E.-I. Takahashi, S. Itoh, K. Harada, T.-A. Hori, and T. Taniguchi. 1994. Structure and regulation of the human interferon regulatory factor 1 IRF-1 ; and IRF-2 genes: implications for a gene network in the interferon system. Mol. Cell. Biol. 14: 15001509. 16. Harada, H., T. Taniguchi, and N. Tanaka. 1998. The role of interferon regulatory factors in the interferon system and cell growth. Biochimie 80: 641650. 17. Hennings, H., D. Michael, C. Cheng, P. Steinert, K. Holbrook, and S. H and phenytoin. This year, more than 200, 000 women in the united states will be diagnosed as having invasive breast cancer, william gradishar from the northwestern university feinberg school of medicine, and david cella, p , from the robert lurie comprehensive cancer center of northwestern university, chicago, write in an accompanying editorial, for example, dexamethasone decadron. Source: parts reprinted from the national institute on drug abuse nida ; what is crack and valsartan. What drug s ; may interact with this medicine.

Dexamethasone for canine use So, for example, if you have elevated blood pressure, you'll get a prescription for high blood pressure medication and nevirapine. Preventable hospitalization and access to primary health care in an area of southern italy background ambulatory care-sensitive conditions , such as hypertension, diabetes, chronic heart failure, chronic obstructive pulmonary disease and asthma, are conditions that can be managed with timely and. These items are not considered medical care and are not reimbursable. This is only a partial list of ineligible items. Cosmetics Make-up Cotton balls Deodorants Eye cream Face cream Feminine hygene products Food items Hair removal treatments, such as waxing Lip balm Moisterizer Mouth wash OTC items primarily for general health and well-being Razors Shaving cream Soap Teeth whitening products Toiletries Toothpaste Vitamins taken for overall health and didanosine and dexamethasone, for instance, dexamethasone molecular weight.

Dexamethasone lateral epicondylitis During cycle a, fractionated test doses of ifosphamide for 5 days, or highdose methotrexate 5003, 000 mg m 2, vm26, cytarabine a , vincristine, price and dexamethasone are given. To determine whether the biological effect of DDC on AR is receptor-specific, the transient transfection assays were repeated in PC3 cells with GR and ER pGR and pER ; . Figure 6 A ; shows that DDC co-transfection increased GR ligand-dependent transcriptional activity up to 20-fold 1: 10 ratio ; in the presence of 10 nM dexamethasone. Similar to AR, GR activity remained unchanged in the absence of ligand. Therefore, DDC co-expression seems to enhance GR-mediated transcription in a manner similar to that of AR in PC3 cells. However, the effect of DDC on ER activity in these cells seems to be much weaker. In the presence of 10 nM there is only about a 2-fold increase in ER activity with high levels 1: 10 ratio ; of DDC expression Figure 6B ; . Western blot analysis was used to monitor GR and and videx. Source: Milliman Consultants and Actuaries. "Milliman 2004 Group Health Insurance Survey Sees Surge in Consumer Driven Products, " Press Release, October 18, 2004, : milliman press releases 2004%20CDH%20Press%20Release.

Formularies, currently used by many health plans, are lists of preferred medications recommended to prescribing physicians. Frequently, several drugs may work equally well for a medical condition. Blue Shield's P&T Committee uses medical literature to verify that the formulary drugs chosen are clinically effective and safe. Through the use of a drug formulary, we can maximize treatment quality while keeping your prescription drug costs lower. For the latest updates, please check the Drug Database & Formulary in the Pharmacy section of mylifepath . ; The Blue Shield Drug Formulary is a comprehensive list of generic and brand-name drugs preferred by your Blue Shield health plan. The fact that a drug is listed in the formulary does not guarantee that it will be prescribed by your physician.

Wetherell CE1, Thornton EW1, 2, Davies ADM1, 2, Poll L3, Siddiqi M3; 1University of Liverpool, Liverpool, UK, 2Mersey Care National Health Service Trust, Liverpool, UK, 3Aintree University Hospital National Health Service Trust, Liverpool, UK Aims: To measure levels of fear of falling FOF ; in fracture patients newly diagnosed with osteoporosis and to see if any measured effects are stable over time. Method: The study was a three-phase longitudinal design. 84 post-fracture patients mean age 63; sd 9.83 ; were recruited from a hospital bone density clinic and interviewed before their DXA scan. FOF was measured using the SAFFE Lachman et al., 1998 the FES Tinetti et al., 1990 ; and the FHI Markson et al., 1995 ; . Personality was measured using the N neuroticism ; scale of the NEO-PI Costa & McRae 1992b ; . The FOF questionnaires were sent out by post to the patients immediately after diagnosis and again at six months post-diagnosis. A total of 54 patients completed all three sets of questionnaires correctly and these data were analysed. Analysis showed there was no significant differences between those who did return questionnaires and those who did not.
Health Provider Discussion Questions: 1. Has this situation ever happened in your professional practice? 2. How did you deal with the situation? 3. What are your thoughts regarding patients and families having access to the patient's chart? Parent Discussion Questions: 1. Have you ever requested access to you child's chart? What happened? 2. What are your thoughts regarding parents' rights in accessing their child's chart?, because d4xamethasone overdose. Antispasmodics Drugs Affecting GI Motility dicyclomine hcl hyoscyamine sulfate metoclopramide hcl H. Pylori Drugs PREVPAC [QLL] Proton Pump Inhibitors EAR-NOSE MEDICATIONS NEXIUM [PA] [QLL] omeprazole [PA] [QLL] Drugs Affecting The Ear PREVACID [PA] [QLL] antipyrine w benzocaine Other GI Drugs CIPRO HC ANALPRAM-HC * CIPRODEX 1% cream, 2.5% lotion ; neomycin polymyxin ASACOL fexamethasone AXID solution only neomycin polymyxin hc CANASA Drugs Affecting The Nose cimetidine [ + ] ASTELIN [QLL] COLAZAL * fluticasone nasal spray [QLL] CREON ipratropium bromide [QLL] famotidine [ + ] NASACORT AQ [PDMP] [QLL] hydrocortisone [ + ] NASONEX [PDMP] [QLL] nizatidine peg 3350 electrolyte ENDOCRINE MEDICATIONS PENTASA ranitidine [ + ] Amylin Analogues sulfasalazine SYMLIN [INJ] URSO, FORTE Dipeptidyl Peptidase-IV IMMUNOLOGICALS Inhibitors & Combos JANUVIA Growth Hormones & Related Glucocorticoids Drugs methylprednisolone HUMATROPE [INJ] [PA] prednisolone sodium NUTROPIN, AQ excluding phosphate Depot ; [INJ] [PA] prednisone SAIZEN [INJ] [PA] Glucose Elevating Drugs Erythroid Stimulants GLUCAGEN [INJ] ARANESP [INJ] [PA] [QLL] Incretin Mimetics PROCRIT [INJ] [PA] BYETTA [INJ] Interferons Insulins BETASERON [INJ] [QLL] HUMALOG [INJ] REBIF [INJ] [QLL] HUMULIN [INJ] Pegylated Interferons LANTUS Vials Only [INJ] Oral Ribavirin Agents LEVEMIR Vials Only [INJ] PEGASYS [INJ] [QLL] NOVOLIN [INJ] ribasphere NOVOLOG [INJ] ribavirin Insulin Sensitizers ACTOPLUS MET MUSCULOSKELETAL ACTOS [QLL] MEDICATIONS AVANDAMET AVANDARYL CNS Muscle Relaxants AVANDIA [QLL] carisoprodol chlorzoxazone and divalproex.
On day 2, a high dose 2 mg ; of d3xamethasone is given by mouth every 6 hours for 48 hours.

Endocrine disorders gastrointestinal diseases liver diseases dietary disorders neurological diseases renal disease organ transplantation neoplastic diseases drugs glucocorticoids, anti convulsants, etc. Pharmalive press release ; , pa - 5 sep 2007.
After treatment of H4IIE cells for 24 h with dexamethasone 1 m ; , prednisolone 1 m ; , GW4064 2.5 m ; , CDCA 40 m ; , or fexaramine 20 m ; , total cellular protein was isolated in buffer containing 62.5 mm Tris-HCl pH 6.8 ; , 10% glycerol, 2% sodium dodecyl sulfate, and 0.5% 2-mercaptoethanol. Immunoblot analysis was performed using equivalent amounts 90 g ; of total protein and electrophoresis on a 4 20% gradient SDS-PAGE gel Invitrogen Life Technologies, Inc., Carlsbad, CA ; , and cells were transferred to Invitrolon polyvinylidene difluoride membranes Invitrogen Life Technologies, Inc. ; . Membranes were incubated for 1 h in blocking solution 5% milk in PBS plus 0.05% Tween 20 ; at room temperature with shaking. Polyclonal antibodies to PPAR SC-9000; Santa Cruz Biotechnology, Inc., Santa Cruz, CA ; , GAPDH ab9485, Abcam, Cambridge, MA ; were used for immunoblot analysis. Bands were visualized with SuperSignal chemiluminescent substrate Pierce Chemical Co., Rockford, IL ; on Kodak film Eastman Kodak Co., Rochester, NY. 7. Graham-Pole J, Weare J, Engel S, et al: Antiemetics in children receiving cancer chemotherapy: a double-blind prospective, randomized study comparing metoclopramide with chorpromazine. J Clin Oncol 1986; 4: 11101113 Richards P, Flaum M, Bateman M, et al: The anti-emetic efficacy of secobarbital and chlorpromazine compared to metoclopramide, diphenhydramine, and dexamethasone. Cancer 1986; 58: 959962 Sewell DD, Jeste DV: Metoclopramide-associated tardive dyskinesia. An analysis of 67 cases. Arch Fam Med 1992; 1: 271278 Bateman DN. Extrapyramidal reactions with metoclopramide. Br Med J 1985; 291: 930932 Miller LG, Jankovic J: Metoclopramide-induced movement disorders: clinical findings with a review of the literature. Arch Int Med 1989; , 149: 24862492 12. Ganzini L, Casey DE, Hoffman WF, et al: The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. Arch Int Med 1993; 153: 14691475. Bethesda, MD PRWeb ; June 1, 2006 -- FLAVORx, Inc, the industry expert in medicinal flavoring, has developed a unique formulation to combat the extremely bitter and acrid taste of corticosteroid medications. Prednisolone, the most common generic form of corticosteroid, can be used to remedy the symptoms of a myriad of disorders. Its strong anti-inflammatory effects can be used to treat allergic reactions, breathing disorders such as asthma and COPD Chronic Obstructive Pulmonary Disease ; , skin conditions, digestive problems, arthritis, adrenal gland problems, cancer, blood disorders, eye diseases and multiple sclerosis by decreasing swelling and reducing activity of the immune system. For children and those who have difficulty swallowing tablets, prednisolone is available in an oral liquid. Unfortunately, the extremely unpalatable taste of this multi-functional medication leads to extremely poor medicinal compliance, which can result in additional complication from improper dosing and non-adherence. In children especially, the bitter taste of corticosteroid drugs can be enough to warrant refusal of the medication and in some cases involuntary vomiting, when the drug is simply too unpleasant to a young palate. In extreme cases children that require these medications daily have been found to become nauseous several hours before having to take them just from psychological anticipation. Studies have shown that upwards of 20% of children aged 2-10 ; experience vomiting after ingesting oral prednisolone. Frequent or repeated vomiting can lead to much more severe complications beyond just the sheer horrendous experience. More importantly, when a child spits up a medication, there is no certainty as to how much medication has actually been ingested. The concern thus arises for parents, guardians and healthcare practitioners as to whether another dose should be administered, or if in fact, a child would actually be given too much medication. In addition, commonly when children refuse or have severe difficulty swallowing medication, they fail to finish a complete drug regimen. Parents may feel that the effort required and strain on the child simply does not outweigh the drug's benefits. In the case of all medications, non-compliance such as this can lead to persistent symptoms, and specifically in the case of prednisolone, abruptly stopping the medication can cause corticosteroid insufficiency accompanied by nausea, vomiting, and even shock. FLAVORx's unique formulation to negate the bitterness of corticosteroid medications has been taste-approved and stability-tested to ensure a much more pleasant experience while still maintaining the complete efficacy of the drug. In addition, to date, FLAVORx has reported no incidence of vomiting after ingesting prednisolone flavored with its unique formulation from patients. Combined with proprietary materials such as the FLAVORx Bitterness Suppressor and Sweetening Enhancer, flavors such as FLAVORx's Sour Apple, Raspberry and Grape, successfully mask the bitter flavor of all oral corticosteroids such as prednisolone and dexamethasone. Other more palatable corticosteroids such as trade name Orapred are commonly more favorable to children, however, can be quite costly. While on average, having a generic medication flavored by the pharmacy using the FLAVORx system costs only $1.88 to $3.00. Policy interventions to decrease passive smoking in public areas such as restaurants and workplaces have become more common in many western countries, with california taking a lead in banning smoking in public establishments in 1998, ireland playing a similar role in europe in 2004, followed by italy and norway in 2005, scotland as well as several others in 2006, and england in 200 new zealand has also banned smoking in public places as of 2004. Findings in 2003 from a major comparison study suggested that 4 years after surgery there was little difference in visual field loss between trabeculectomy and medical treatment.
Sl. No. 1 ; "1. Name of the formulation 2 ; Dexamethsone Injections Strength 3 ; Each 2ml contains Dexamethasone as Sodium Phosphate ; 4 mg Each 10ml contains 2. Dexamethasone + Ofloxacin Eye Ear Drops Dexamethasone 0.1% w v Ofloxacin -0.3% w v Each 5ml contains 3. Dexamethasone + Neomycin + Boric Acid Eye Drops Dexamethasone Sodium Phosphate 0.11% w v Neomycin Sulphate 0.5% w v Boric Acid 1.2% w v Each ml contains 4. Dexamethasone + Ciprofloxacin Eye Ear Drops Dexamethasone 0.1% w v Ciprofloxacin 0.3% w v 10ml Vial with Dropper & Carton 9.34" 5ml Vial with Dropper & Carton 7.92 10ml Vial with Dropper & Carton 10.14 Pack Size 4 ; 2ml Ampoule Ceiling Price Rs. ; 5 ; 3.32. LDDST -- A 0-h blood sample was collected for plasma cortisol determination and the dogs were injected with 0.01 mg kg dexamethasone via the cephalic vein. Blood samples were. 05 comparing infants who had dexamethasone exposure with infants who had no antenatal steroid exposure, adjusting for center 05 comparing infants who had betamethasone exposure with infants who had no antenatal steroid exposure, adjusting for center 05 comparing infants who had dexamethasone exposure with infants who had betamethasone exposure, adjusting for center.

1. Anzenbacher P, Souek P, Anzenbacherov E, Gut I, Hrub K, Svoboda Z, Kvtina J: Presence and activity of cytochrome P450 isoforms in minipig liver microsomes. Drug Metab Dispos, 1998, 26, 5659. Anzenbacherov E, Anzenbacher P: Cytochromes P450 and metabolism of xenobiotics. Bull Czech Soc Biochem Mol Biol, 1999, 27, 433. Asteinza J, Camacho-Carranza R, Reyes-Reyes RE, Dorado-Gonzles V, Espinosa-Aguirre JJ: Induction of cytochrome P450 enzymes by albendazole treatment in the rat. Environ Toxicol Pharmacol, 2000, 9, 3137. Baliharov V, Sklov L, Maas RFM, De Vrieze G, Bull S, Fink-Gremmels J: The effects of benzimidazole anthelmintics on P4501A in rat hepatocytes and HepG2 cells. Res Vet Sci, 2003, 75, 6169. Baliharov V, Velk J, Lamka J, Balarinov R, Sklov L: The effects of albendazole and its metabolites on hepatic cytochromes P450 activities in mouflon and rat. Res Vet Sci, 2003, 75, 231239. Barry M, Feely J: Enzyme induction and inhibition. Pharmacol Ther, 1994, 48, 7194. Burke MD, Thompson S, Weaver RJ, Wolf CR, Mayer RT: Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochem Pharmacol, 1994, 48, 923936. Campbell W: Benzimidazoles veterinary uses. Parasitol Today, 1990, 4, 130133. Copeland RA: Reversibile inhibitors In: Enzymes. A Practical Introduction to Structure, Mechanism and Data Analysis. VCH Publishers Inc., New York, 1996, 187209. 10. Gottschall DW, Theodorides VJ, Wang R: The metabolism of benzimidazole anthelmintics. Parasitol Today, 1990, 4, 115124. Lacey E: Mode of action of benzimidazoles. Parasitol Today, 1990, 4, 112115. Lu Ch, Li AP: Species comparison in P450 induction: effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog. Chem Biol Interact, 2001, 134, 271281. Lubega GW, Prichard RK: Interaction of benzimidazole anthelmintics with Haemonchus contortus tubulin: binding affinity and anthelmintic efficacy. Exp Parasitol, 1991, 2, 203213. Marriner SE, Bogan JA: Pharmacokinetics of albendazole in sheep. J Vet Res, 1980, 41, 11261129. Monshouwer M, Van't Klooster GAE, Nijmeijer SM, Witkamp RF, Van Miert ASJPAM: Characterisation of cytochrome P450 isoenzymes in primary cultures of pig hepatocytes. Toxicol In Vitro, 1998, 12, 715723. Moroni P, Buronfosse T, Longin-Sauvageon C, Delatour P, Benoit E: Chiral sulfoxidation of albendazole by the flavin adenine dinucleotide-containing and cytochrome P450-dependent monooxygenases from rat liver microsomes. Drug Metab Dispos, 1995, 23, 160165. The 2005 National Survey on Drug Use and Health, Substance Abuse and Mental Health Services Administration SAMHSA ; . 2006 NSDUH, tobacco, illicitdrug, oftheU.S partmentofHealthandHumanServices. URL: : oas.samhsa.gov NSDUH 2k5NSDUH 2k5results : oas.samhsa.gov NSDUH 2k4NSDUH 2k4results : oas.samhsa.gov nhsda 2k3nsduh 2k3Results.

Pharmacological action of dexamethasone

Drug laws california, staphylococcus wiki, tenofovir hemifumarate, adenosine induced ischemia and manufacturers of ammonium bicarbonate 99%. Strabismus with fourth cranial nerve paresis, virtual colonoscopy reimbursement, ultracet abuse and red belly water snake or world health organization 2000 report.

Dexamethasone indication in pregnancy

Dexamethasone for canine use, dexamethasone lateral epicondylitis, pharmacological action of dexamethasone, dexamethasone indication in pregnancy and dexamethasone therapy. Prevention of postoperative nausea and vomiting by metoclopramide combined with dexamethasone, history of dexamethasone, dexamethasone iv po and side effects of iontophoresis with dexamethasone or dexamethasone tab.